Cargando…

Relapses of Plasmodium vivax malaria threaten disease elimination: time to deploy tafenoquine in India?

Detalles Bibliográficos
Autores principales:	Ahmad, Sundus Shafat, Rahi, Manju, Sharma, Amit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903102/ https://www.ncbi.nlm.nih.gov/pubmed/33619041 http://dx.doi.org/10.1136/bmjgh-2020-004558

Ejemplares similares

Coverage enhancement and community empowerment via commercial availability of the long-lasting nets for malaria in India
por: Rahi, Manju, et al.
Publicado: (2021)

Tafenoquine for preventing relapse in people with Plasmodium vivax malaria
por: Rajapakse, Senaka, et al.
Publicado: (2015)

Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria
por: Llanos-Cuentas, A., et al.
Publicado: (2019)

Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria
por: Lacerda, M.V.G., et al.
Publicado: (2019)

Ivermectin as an endectocide may boost control of malaria vectors in India and contribute to elimination
por: Ahmad, Sundus Shafat, et al.
Publicado: (2022)

Should India be considering deployment of the first malaria vaccine RTS, S/AS01?
por: Rahi, Manju, et al.
Publicado: (2022)

For malaria elimination India needs a platform for data integration
por: Rahi, Manju, et al.
Publicado: (2020)

Tafenoquine for Plasmodium vivax malaria: Concerns regarding efficacy & safety
por: Sharma, Jatin, et al.
Publicado: (2021)

Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date
por: Ebstie, Yehenew A, et al.
Publicado: (2016)

Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria
por: St Jean, Pamela L., et al.
Publicado: (2020)

Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review
por: Duparc, Stephan, et al.
Publicado: (2020)

Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study
por: Nekkab, Narimane, et al.
Publicado: (2021)

Cost-Benefit Analysis of Tafenoquine for Radical Cure of Plasmodium vivax Malaria in Korea
por: Suh, Jiyeon, et al.
Publicado: (2022)

Malaria control initiatives that have the potential to be gamechangers in India's quest for malaria elimination
por: Rahi, Manju, et al.
Publicado: (2022)

Mefloquine as a prophylaxis for malaria needs to be revisited
por: Ahmad, Sundus Shafat, et al.
Publicado: (2021)

Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data
por: Hounkpatin, Aurore B, et al.
Publicado: (2019)

Safety and Efficacy of Tafenoquine for Plasmodium vivax Malaria Prophylaxis and Radical Cure: Overview and Perspectives
por: Markus, Miles B
Publicado: (2021)

India could harness public-private partnerships to achieve malaria elimination
por: Rahi, Manju, et al.
Publicado: (2022)

Tafenoquine for the radical cure versus prophylaxis of Plasmodium vivax malaria: the importance of using the appropriate data set
por: Sharma, Raman, et al.
Publicado: (2023)

Missed Plasmodium falciparum and Plasmodium vivax Mixed Infections in Ethiopia Threaten Malaria Elimination
por: Leonard, Colleen M., et al.
Publicado: (2022)

Connecting the dots to strengthen malaria elimination strategies in India: A Malaria Elimination Research Alliance - India initiative
por: Rahi, Manju, et al.
Publicado: (2021)

Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping
por: Beck, Hans-Peter, et al.
Publicado: (2016)

Supervised administration of primaquine may enhance adherence to radical cure for P. vivax malaria in India
por: Rahi, Manju, et al.
Publicado: (2023)

Tafenoquine: A 2018 Novel FDA-Approved Prodrug for the Radical Cure of Plasmodium vivax Malaria and Prophylaxis of Malaria
por: Mayence, Annie, et al.
Publicado: (2019)

The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis
por: Watson, James A, et al.
Publicado: (2022)

Insights into the elimination of vivax malaria in China
por: Huang, Fang, et al.
Publicado: (2023)

Elimination of Plasmodium vivax Malaria in Azerbaijan
por: Mammadov, Suleyman, et al.
Publicado: (2016)

What India can learn from globally successful malaria elimination programmes
por: Sharma, Sachin, et al.
Publicado: (2022)

Management of relapsing Plasmodium vivax malaria
por: Chu, Cindy S, et al.
Publicado: (2016)

Relapse of Plasmodium vivax and Plasmodium ovale Malaria With and Without Primaquine Treatment in a Nonendemic Area
por: Wångdahl, Andreas, et al.
Publicado: (2021)

Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial
por: St Jean, Pamela L., et al.
Publicado: (2016)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
por: Watson, James, et al.
Publicado: (2018)

COVID-19 and Plasmodium vivax malaria co-infection
por: Sardar, Sundus, et al.
Publicado: (2020)

India can consider integration of three eliminable disease control programmes on malaria, lymphatic filariasis, and visceral leishmaniasis
por: Rahi, Manju, et al.
Publicado: (2021)

Determinants of relapse periodicity in Plasmodium vivax malaria
por: White, Nicholas J
Publicado: (2011)

Correction: India can consider integration of three eliminable disease control programmes on malaria, lymphatic filariasis, and visceral leishmaniasis
por: Rahi, Manju, et al.
Publicado: (2022)

Insecticide resistance status of malaria vectors in the malaria endemic states of India: implications and way forward for malaria elimination
por: Raghavendra, Kamaraju, et al.
Publicado: (2022)

Is zoonotic Plasmodium vivax malaria an obstacle for disease elimination?
por: Chaves, Bárbara Aparecida, et al.
Publicado: (2022)

Epidemiology of Plasmodium vivax Malaria in India
por: Anvikar, Anupkumar R., et al.
Publicado: (2016)

Plasmodium vivax malaria vaccines: Why are we where we are?
por: Reyes-Sandoval, Arturo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qjfh1fvt6fkh1je0u461hg4t00